# Seizure Prophylaxis in Patients With Glioma or Brain Metastasis

> **NCT03436433** · PHASE2 · TERMINATED · sponsor: **Duke University** · enrollment: 4 (actual)

## Conditions studied

- Glioma
- Glioma of Brain
- Brain Tumor

## Interventions

- **DRUG:** Lacosamide
- **DRUG:** Levetiracetam

## Key facts

- **NCT ID:** NCT03436433
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-01-31
- **Primary completion:** 2020-12-04
- **Final completion:** 2020-12-04
- **Target enrollment:** 4 (ACTUAL)
- **Why stopped:** Did not enroll as planned
- **Last updated:** 2023-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03436433

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03436433, "Seizure Prophylaxis in Patients With Glioma or Brain Metastasis". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03436433. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*